Agronomics Ltd (ANIC)

Industry Asset Management

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

6.20p

Buy

6.70p

arrow-up0.01p (+0.16%)

Port Erin Biopharma Investments Ltd invests in biopharmaceutical sector. Its objective is to create value for shareholders through investing in companies that have potential to generate substantial revenues through development of biopharmaceutical drugs.
Prices updated at 09 May 2025, 16:19 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Sector
Financial Services
Industry
Asset Management
Chairman
Mr. James Mellon
CEO
-
Most recent earnings
30 Jun 2024
Fiscal year end
30 Jun 2024
Employees
-
Head office
1st Floor, Viking House
Ramsey
Isle of Man
IM8 1GB
mobile
+44 1624811451
letter
info@agronomics.im

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Richard John Reed
Non-Executive Director
---0.04m-
Mr. David Anthony Giampaolo
Non-Executive Director
---0.03m-
Mr. Denham Hervey Newall Eke
Executive Director, Finance Director
-----
Mr. James Mellon
Executive Director, Chairman
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Marlborough International Management Limited7,500,0000.05312--30 Apr 20250.74
Marlborough Special Situations Cell7,500,0000.05312--30 Apr 20250.74
Hargreave Hale Limited6,590,0000.04759-8924000-30 Apr 20250.65
IFSL Marlborough UK Micro Cap Growth6,590,0000.04759-8924000-57.52223830 Apr 20250.65
Picard Angst AG4,457,6320.68507--30 Apr 20250.44

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
04 Feb 2025PurchaseMr. James Mellon380.004,940,000160,406,55115.89-
10 Oct 2024PurchaseMr. James Mellon4.9249,200159,106,55115.76-
07 Oct 2024PurchaseMr. James Mellon4.8496,875158,106,55115.66-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.